Literature DB >> 11408335

Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis.

P D Murray1, D B McGavern, S Sathornsumetee, M Rodriguez.   

Abstract

A major question in neurobiology is whether myelin repair can restore neurological function following the course of a severe, progressive CNS demyelinating disease that induces axonal loss. In this study we used Theiler's murine encephalomyelitis virus (TMEV) to induce a chronic progressive CNS demyelinating disease in mice that was immune-mediated and pathologically similar to human multiple sclerosis. Because immunosuppression of chronically TMEV-infected mice has been shown to enhance myelin repair, we first addressed the potential roles of CD4(+) and CD8(+) T cells in the inhibition of CNS remyelination during chronic disease. TMEV infection of susceptible PL/J mice deficient in CD4(+) but not CD8(+) T cells demonstrated a significant increase in severity of pathogenesis when compared with wild-type controls. This was characterized by enhanced demyelination, spinal cord atrophy, neurological deficits, and mortality. Interestingly, the PL/J CD4(-/-) mice that survived to the chronic stage of the disease had nearly complete spontaneous myelin repair mediated by both oligodendrocytes and infiltrating Schwann cells. Therefore, we next addressed whether this spontaneous myelin repair was associated with improved neurological function despite the increased pathology. Of interest, all surviving PL/J CD4(-/-) mice showed partial restoration of motor coordination and gait that coincided temporally with spontaneous myelin repair. Furthermore, functional recovery of motor coordination correlated strongly with the percentage of myelin repair mediated by Schwann cells, whereas restoration of hindlimb gait correlated with oligodendrocyte-mediated myelin repair. This is the first study to demonstrate that spontaneous remyelination correlates with partial restoration of neurological function during the course of a progressive, immune-mediated CNS demyelinating disease. Of greater importance, functional recovery occurred despite previous severe demyelination and spinal cord atrophy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408335      PMCID: PMC5455988          DOI: 10.1093/brain/124.7.1403

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  50 in total

1.  Quantitative ultrastructural analysis of a single spinal cord demyelinated lesion predicts total lesion load, axonal loss, and neurological dysfunction in a murine model of multiple sclerosis.

Authors:  S Sathornsumetee; D B McGavern; D R Ure; M Rodriguez
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Multiple sclerosis. Animal model:Theiler's virus infection in mice.

Authors:  M C Dal Canto; H L Lipton
Journal:  Am J Pathol       Date:  1977-08       Impact factor: 4.307

3.  Restoration of normal conduction properties in demyelinated spinal cord axons in the adult rat by transplantation of exogenous Schwann cells.

Authors:  O Honmou; P A Felts; S G Waxman; J D Kocsis
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

4.  CD8 is needed for development of cytotoxic T cells but not helper T cells.

Authors:  W P Fung-Leung; M W Schilham; A Rahemtulla; T M Kündig; M Vollenweider; J Potter; W van Ewijk; T W Mak
Journal:  Cell       Date:  1991-05-03       Impact factor: 41.582

Review 5.  T-cell development and function in gene-knockout mice.

Authors:  R S Yeung; J Penninger; T W Mak
Journal:  Curr Opin Immunol       Date:  1994-04       Impact factor: 7.486

6.  Theiler's virus-induced demyelination: prevention by immunosuppression.

Authors:  H L Lipton; M C Dal Canto
Journal:  Science       Date:  1976-04-02       Impact factor: 47.728

7.  Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion.

Authors:  C S Raine; L Scheinberg; J M Waltz
Journal:  Lab Invest       Date:  1981-12       Impact factor: 5.662

8.  Oligodendrocytes in the early course of multiple sclerosis.

Authors:  W Brück; M Schmied; G Suchanek; Y Brück; H Breitschopf; S Poser; S Piddlesden; H Lassmann
Journal:  Ann Neurol       Date:  1994-01       Impact factor: 10.422

9.  Demyelination induced by Theiler's virus: influence of the H-2 haplotype.

Authors:  M Rodriguez; C S David
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

10.  Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis.

Authors:  M Rodriguez; J L Leibowitz; P W Lampert
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

View more
  23 in total

1.  Inflammation and remyelination in the central nervous system: a tale of two systems.

Authors:  Francesca Ruffini; Timothy E Kennedy; Jack P Antel
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

Review 2.  Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis.

Authors:  Ales Dudesek; Uwe K Zettl
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

3.  Combination of engineered Schwann cell grafts to secrete neurotrophin and chondroitinase promotes axonal regeneration and locomotion after spinal cord injury.

Authors:  Haruo Kanno; Yelena Pressman; Alison Moody; Randall Berg; Elizabeth M Muir; John H Rogers; Hiroshi Ozawa; Eiji Itoi; Damien D Pearse; Mary Bartlett Bunge
Journal:  J Neurosci       Date:  2014-01-29       Impact factor: 6.167

4.  Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced primate Schwann cells lead to functional recovery of the demyelinated mouse spinal cord.

Authors:  Christelle Girard; Alexis-Pierre Bemelmans; Noëlle Dufour; Jacques Mallet; Corinne Bachelin; Brahim Nait-Oumesmar; Anne Baron-Van Evercooren; François Lachapelle
Journal:  J Neurosci       Date:  2005-08-31       Impact factor: 6.167

Review 5.  Stem cell therapy for central nervous system demyelinating disease.

Authors:  Louis N Manganas; Mirjana Maletic-Savatic
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

6.  Decellularized peripheral nerve supports Schwann cell transplants and axon growth following spinal cord injury.

Authors:  Susana R Cerqueira; Yee-Shuan Lee; Robert C Cornelison; Michaela W Mertz; Rebecca A Wachs; Christine E Schmidt; Mary Bartlett Bunge
Journal:  Biomaterials       Date:  2018-05-28       Impact factor: 12.479

Review 7.  Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.

Authors:  Jens Watzlawik; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2010-03       Impact factor: 4.618

8.  Oligodendrocytes engineered with migratory proteins as effective graft source for cell transplantation in multiple sclerosis.

Authors:  Ike de la Pena; Mibel Pabon; Sandra Acosta; Paul R Sanberg; Naoki Tajiri; Yuji Kaneko; Cesar V Borlongan
Journal:  Cell Med       Date:  2014-04-10

9.  The Biology of Persistent Infection: Inflammation and Demyelination following Murine Coronavirus Infection of the Central Nervous System.

Authors:  Martin P Hosking; Thomas E Lane
Journal:  Curr Immunol Rev       Date:  2009-05-04

10.  Extensive remyelination of the CNS leads to functional recovery.

Authors:  I D Duncan; A Brower; Y Kondo; J F Curlee; R D Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.